These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 9603321)

  • 1. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.
    Huvent I; Hong SS; Fournier C; Gay B; Tournier J; Carrière C; Courcoul M; Vigne R; Spire B; Boulanger P
    J Gen Virol; 1998 May; 79 ( Pt 5)():1069-81. PubMed ID: 9603321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing.
    Bardy M; Gay B; Pébernard S; Chazal N; Courcoul M; Vigne R; Decroly E; Boulanger P
    J Gen Virol; 2001 Nov; 82(Pt 11):2719-2733. PubMed ID: 11602784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
    Sova P; Volsky DJ; Wang L; Chao W
    J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.
    Bouyac M; Courcoul M; Bertoia G; Baudat Y; Gabuzda D; Blanc D; Chazal N; Boulanger P; Sire J; Vigne R; Spire B
    J Virol; 1997 Dec; 71(12):9358-65. PubMed ID: 9371595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles.
    Carrière C; Gay B; Chazal N; Morin N; Boulanger P
    J Virol; 1995 Apr; 69(4):2366-77. PubMed ID: 7884882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation.
    Zhang Y; Barklis E
    J Virol; 1997 Sep; 71(9):6765-76. PubMed ID: 9261401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.
    Dafonseca S; Coric P; Gay B; Hong SS; Bouaziz S; Boulanger P
    Virol J; 2008 Dec; 5():162. PubMed ID: 19105849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.
    Wagner R; Deml L; Fliessbach H; Wanner G; Wolf H
    Virology; 1994 Apr; 200(1):162-75. PubMed ID: 7510434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.
    Chazal N; Gay B; Carrière C; Tournier J; Boulanger P
    J Virol; 1995 Jan; 69(1):365-75. PubMed ID: 7983731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
    Checroune F; Yao XJ; Göttlinger HG; Bergeron D; Cohen EA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):1-7. PubMed ID: 7648278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag.
    Sandefur S; Varthakavi V; Spearman P
    J Virol; 1998 Apr; 72(4):2723-32. PubMed ID: 9525590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.
    Zhang H; Pomerantz RJ; Dornadula G; Sun Y
    J Virol; 2000 Sep; 74(18):8252-61. PubMed ID: 10954522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. trans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1.
    Kaye JF; Lever AM
    J Virol; 1996 Feb; 70(2):880-6. PubMed ID: 8551627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.
    Chazal N; Carrière C; Gay B; Boulanger P
    J Virol; 1994 Jan; 68(1):111-22. PubMed ID: 8254720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor.
    Schäfer A; Bogerd HP; Cullen BR
    Virology; 2004 Oct; 328(2):163-8. PubMed ID: 15464836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag).
    Sandefur S; Smith RM; Varthakavi V; Spearman P
    J Virol; 2000 Aug; 74(16):7238-49. PubMed ID: 10906178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single point mutations in the zinc finger motifs of the human immunodeficiency virus type 1 nucleocapsid alter RNA binding specificities of the gag protein and enhance packaging and infectivity.
    Mark-Danieli M; Laham N; Kenan-Eichler M; Castiel A; Melamed D; Landau M; Bouvier NM; Evans MJ; Bacharach E
    J Virol; 2005 Jun; 79(12):7756-67. PubMed ID: 15919928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain.
    Zhang Y; Qian H; Love Z; Barklis E
    J Virol; 1998 Mar; 72(3):1782-9. PubMed ID: 9499028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gag-Gag interactions in the C-terminal domain of human immunodeficiency virus type 1 p24 capsid antigen are essential for Gag particle assembly.
    Zhang WH; Hockley DJ; Nermut MV; Morikawa Y; Jones IM
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():743-51. PubMed ID: 8627263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.